Office Of Regulatory Affairs Faces Training, Retirement Challenges
This article was originally published in The Gray Sheet
Executive Summary
With better funding than ever for enforcement activities, FDA's Office of Regulatory Affairs is looking to new challenges, including training an influx of new investigators and adjusting to the retirement of its most experienced staffers